Agios Pharmaceuticals (AGIO) Cash from Operations (2012 - 2026)
Agios Pharmaceuticals (AGIO) posted Cash from Operations of 118920000.0 for Q1 2026, down 23.6% on a QoQ basis from 96213000.0 in Q4 2025, and down 6.67% year-over-year from 127412326.59 in Q1 2025.
Agios Pharmaceuticals (AGIO) Cash from Operations (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals' Cash from Operations history runs 15 years deep, the most recent figure standing at 118920000.0 for Q1 2026.
- Quarterly Cash from Operations fell 6.67% year-over-year to 118920000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 380408000.0 (up 5.24% YoY) and the FY2025 annual result came in at 372977000.0, up 4.33% from the prior year.
- Cash from Operations was 118920000.0 for Q1 2026 at Agios Pharmaceuticals, down from 96213000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 61643000.0 in Q3 2023 and bottomed at 133167000.0 in Q4 2024.
- A 5-year average of 87486941.18 and a median of 84218000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations soared 56.49% — and 2024, when it plunged 83.71%.
- Agios Pharmaceuticals' Cash from Operations stood at 66163000.0 in 2022, then dropped by 9.56% to 72488000.0 in 2023, then plunged by 83.71% to 133167000.0 in 2024, then climbed by 27.75% to 96213000.0 in 2025, then retreated by 23.6% to 118920000.0 in 2026.
- Business Quant data shows AGIO's Cash from Operations at 118920000.0 in Q1 2026, 96213000.0 in Q4 2025, and 88151000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | -118.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.92 Mn |
| Mar 31, 2026 | -118.92 Mn |
| Dec 31, 2025 | -96.21 Mn |
| Dec 31, 2025 | -96.21 Mn |
| Sep 30, 2025 | -88.15 Mn |
| Sep 30, 2025 | -88.15 Mn |
| Jun 30, 2025 | -77.12 Mn |
| Jun 30, 2025 | -77.12 Mn |
| Mar 31, 2025 | -111.49 Mn |
| Mar 31, 2025 | -111.49 Mn |
| Dec 31, 2024 | -133.17 Mn |
| Dec 31, 2024 | -133.17 Mn |
| Sep 30, 2024 | -84.22 Mn |
| Sep 30, 2024 | -84.22 Mn |
| Jun 30, 2024 | -72.59 Mn |
| Jun 30, 2024 | -72.59 Mn |
| Mar 31, 2024 | -99.87 Mn |
| Mar 31, 2024 | -99.87 Mn |
| Dec 31, 2023 | -72.49 Mn |
| Dec 31, 2023 | -72.49 Mn |